CAS 1699717-32-2

3-ethyl-6-[(4-hydroxy-1-piperidinyl)carbonyl]-5-methyl-1-(3,3,3-trifluoropropyl)-thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione

CAS : 1699717-32-2

Formule : C₁₈H₂₂F₃N₃O₄S

Degré de pureté : 98%

Masse moléculaire : 433.4452

Ref: IN-DA01LJ06

BAY-545

CAS : 1699717-32-2

BAY-545

Degré de pureté : ≥95%

Masse moléculaire : 433.45g/mol

Ref: 54-BUP09530

BAY-545

CAS : 1699717-32-2

BAY-545 is an antagonist of A2B adenosine receptor(IC50 : 59 nM).

Formule : C₁₈H₂₂F₃N₃O₄S

Degré de pureté : 98.05%

Couleur et forme : Solid

Masse moléculaire : 433.45

Ref: TM-T8512

3-Ethyl-6-(4-hydroxypiperidine-1-carbonyl)-5-methyl-1-(3,3,3-trifluoropropyl)thieno[2,3-d]pyrimidine-2,4(1H,3H)-dione

CAS : 1699717-32-2

Formule : C₁₈H₂₂F₃N₃O₄S

Degré de pureté : 98%

Masse moléculaire : 433.45

Ref: 10-F544997

BAY-545

CAS : 1699717-32-2

BAY-545 is a small molecule inhibitor, which is synthetically developed with precise activity targeting cyclin-dependent kinases (CDKs). It serves as a critical advancement in understanding the pharmacological modulation of key regulatory proteins involved in cell cycle progression. BAY-545 exerts its effects by selectively inhibiting specific CDKs, thereby altering the phosphorylation status of downstream targets. This inhibition disrupts the cell cycle, leading to cell cycle arrest and potentially inducing apoptosis in cancerous cells.

Formule : C₁₈H₂₂F₃N₃O₄S

Degré de pureté : Min. 95%

Masse moléculaire : 433.45 g/mol

Ref: 3D-ZSC71732